Penserra Capital Management LLC Regenxbio Inc. Transaction History

Penserra Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$30.19 - $40.28 $29,435 - $39,273	-975 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$29.09 - $45.68 $145 - $228	5 Added 0.52%	975 $40,000
Q2 2021 Aug 12, 2021	BUY	$32.46 - $40.48 $486 - $607	15 Added 1.57%	970 $37,000
Q1 2021 May 13, 2021	BUY	$33.61 - $49.95 $3,192 - $4,745	95 Added 11.05%	955 $32,000
Q4 2020 Feb 12, 2021	BUY	$26.52 - $49.35 $14,320 - $26,649	540 Added 168.75%	860 $39,000
Q3 2020 Nov 13, 2020	BUY	$27.01 - $40.26 $8,643 - $12,883	320 New	320 $8,000
Q3 2018 Nov 05, 2018	SELL	$65.0 - $82.15 $109,980 - $138,997	-1,692 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$27.2 - $74.35 $46,022 - $125,800	1,692 New	1,692 $121,000

196

43M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $329M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.